Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.6
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2013
Mar. 31, 2012
Revenues:    
Product $ 9,137 $ 15,167
Collaborative research and development 2,344 14,612
Government awards 0 1,357
Total revenues 11,481 31,136
Costs and operating expenses:    
Cost of product revenues 5,665 12,642
Research and development 7,322 16,349
Selling, general and administrative 8,124 9,395
Total costs and operating expenses 21,111 38,386
Loss from operations (9,630) (7,250)
Interest income 27 75
Other expenses (85) (118)
Loss before provision (benefit) for income taxes (9,688) (7,293)
Provision (benefit) for income taxes (65) 197
Net loss $ (9,623) $ (7,490)
Net loss per share of common stock, basic and diluted (dollars per share) $ (0.25) $ (0.21)
Weighted average common shares used in computing net loss per share of common stock, basic and diluted (shares) 37,842 36,057